A Q1 2026 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q1 2026 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.8B+7.0% YoY

Gross Profit

$946M52.6% margin

Operating Income

$353M19.6% margin

Net Income

$305M17.0% margin

EPS (Diluted)

$1.07

QoQ Revenue Growth

-3.4%

Cash Flow

Operating Cash Flow

$268M

Free Cash Flow

$175M

Stock-Based Comp.

$41M

Balance Sheet

Total Assets

$12.8B

Total Liabilities

$5.9B

Stockholders' Equity

$6.9B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.8B	$1.7B	+7.0%
Gross Profit	$946M	$899M	+5.2%
Operating Income	$353M	$376M	-6.1%
Net Income	$305M	$318M	-4.1%

Revenue Segments

Agilent CrossLab

$758M42%

Life Sciences and Applied Markets

$679M38%

Applied Markets

$361M20%

Geographic Segments

Americas

$678M38%

Asia Pacific

$602M33%

Europe

$518M29%